Drs. Geoffrey Oxnard and Lauren Ritterhouse deliberate on ways reimbursement issues are impacting clinical practice, particularly CMS’s “14-Day Rule.”
Video Library —December 18, 2018
Categories:
Interview with the InnovatorsThoracic Oncologist, Dana-Farber Cancer Institute,
Associate Professor of Medicine, Harvard Medical School,
Boston, MA
Associate Professor of Medicine, Harvard Medical School,
Boston, MA
Molecular Pathologist and Co-Director
Molecular Diagnostics and Clinical Genomics Laboratories, University of Chicago
Chicago, IL
Molecular Diagnostics and Clinical Genomics Laboratories, University of Chicago
Chicago, IL
Last modified: August 10, 2023